Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Bliss GVS Pharma Limited (NSE: BLISSGVS), ISIN INE416D01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BLISSGVS last traded at ₹648.05 (+5.50%), with a 52-week range of ₹118.00 to ₹739.90 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 50.07%, FIIs 5.03%, DIIs 9.62%, mutual funds 0.00%.
EquiSense Score (ECS): 71/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.